[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
[HTML][HTML] COVID-19 and hypertension: the what, the why, and the how
It has been a year since the coronavirus disease 2019 (COVID-19) was declared pandemic
and wreak havoc worldwide. Despite meticulous research has been done in this period …
and wreak havoc worldwide. Despite meticulous research has been done in this period …
[HTML][HTML] Retinal manifestations in patients following COVID-19 infection: A consecutive case series
M Goyal, SI Murthy, S Annum - Indian journal of ophthalmology, 2021 - journals.lww.com
Purpose: To describe retinal manifestations seen in patients associated with COVID-19
infection at a multi-specialty tertiary care hospital in Southern India. Methods: In this …
infection at a multi-specialty tertiary care hospital in Southern India. Methods: In this …
[HTML][HTML] Circulating microRNAs as emerging regulators of COVID-19
Y Liang, D Fang, X Gao, X Deng, N Chen, J Wu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …
Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action
MA Hill, JR Sowers, CS Mantzoros - Metabolism, 2021 - Elsevier
While substantial evidence points towards obesity and associated cardiometabolic disorders
being a major factor for poor outcomes in SARS-CoV2 infections (COVID-19), the complexity …
being a major factor for poor outcomes in SARS-CoV2 infections (COVID-19), the complexity …
[HTML][HTML] Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease
2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review …
2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review …
[HTML][HTML] Resveratrol as an adjunctive therapy for excessive oxidative stress in aging COVID-19 patients
MT Liao, CC Wu, SFV Wu, MC Lee, WC Hu, KW Tsai… - Antioxidants, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic continues to burden healthcare
systems worldwide. COVID-19 symptoms are highly heterogeneous, and the patient may be …
systems worldwide. COVID-19 symptoms are highly heterogeneous, and the patient may be …
Stimuli-responsive and biomimetic delivery systems for sepsis and related complications
EA Ismail, N Devnarain, T Govender… - Journal of Controlled …, 2022 - Elsevier
Sepsis, a consequence of an imbalanced immune response to infection, is currently one of
the leading causes of death globally. Despite advances in the discoveries of potential …
the leading causes of death globally. Despite advances in the discoveries of potential …
Characterisation of cardiac pathology in 23 autopsies of lethal COVID‐19
Abstract While coronavirus disease 2019 (COVID‐19) primarily affects the respiratory tract,
pathophysiological changes of the cardiovascular system remain to be elucidated. We …
pathophysiological changes of the cardiovascular system remain to be elucidated. We …
[HTML][HTML] Capillary leukocytes, microaggregates, and the response to hypoxemia in the microcirculation of coronavirus disease 2019 patients
OBJECTIVES: In this study, we hypothesized that coronavirus disease 2019 patients exhibit
sublingual microcirculatory alterations caused by inflammation, coagulopathy, and …
sublingual microcirculatory alterations caused by inflammation, coagulopathy, and …